BioCardia to hold annual say-on-pay votes following stockholder approval

BioCardia, Inc.

Board recommended annual frequency; stockholders approved at Oct 18, 2023 meeting.
Decision disclosed via this 8-K/A amendment to original 8-K.
Next advisory vote on frequency will occur when required.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BioCardia, Inc. shareholders approved Frequency of future stockholder advisory votes on the compensation of its named executive officers at the 2023-10-18 meeting.

Proposal: say on pay frequency
Outcome: passed
Meeting: 2023-10-18

Exact text from the filing

The Company will hold future say on pay votes on an annual basis, as was recommended by the Company’s Board of Directors in the Company’s proxy statement for the 2023 annual meeting of stockholders held on October 18, 2023 (the "2023 Annual Meeting") and was subsequently approved by the Company’s stockholders at the 2023 Annual Meeting

View on SEC.gov

Browse all shareholder votes →

BioCardia, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-23-033648

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.